Vineeta Agarwala

General Partner

2020 - Current

We invest in biotech and health tech companies that are changing the world through the engineering of biology and the innovation of care delivery. Board Director at several of our portfolio companies: Amber Bio, BigHat Biosciences, Function Oncology, Gate Bioscience, GC Therapeutics, Knownwell, Orbital Therapeutics, Rezo Therapeutics, Memora Health, Pearl Health, Pomelo Care, Thyme Care, and Waymark

Adjunct Clinical Assistant Professor

2020

I am a physician focused on cancer survivorship. My clinic is part of the Division of Primary Care and Population Health.

Board Director

2024

Board Member

2021

Committee Member

2021

Member of the Committee to Visit the Harvard Medical School and School of Dental Medicine.

Venture Partner

2015 - 2019

Board Director at Maze Therapeutics. Was privileged to lead diligence and support early stage investments in amazing teams including SQZ Biotech ($SQZ), Spero Therapeutics ($SPRO), Ideaya Biosciences ($IDYA), Foghorn Therapeutics ($FHTX), Locana Bio, Arrakis Therapeutics, Kindbody, and others. Evaluated investment opportunities and worked with portfolio companies across biotech, diagnostics, platform tools, and digital health.

Director, Product Management

2016 - 2018

Helped to build an oncology network and data platform of unprecedented scale. Led partnership with Foundation Medicine to link real-world clinical and genomic datasets.

Product Manager

2015 - 2016

MD/PhD

2008 - 2015

Studied genetic causes of common human diseases. Focus on population genetics, analysis and interpretation of next-generation sequencing data, and clinical translation.

Data Scientist

2010 - 2012

Kyruus is a big data start-up which provides patient access and referral management solutions to health systems.

Business Analyst

2007 - 2008

Operations, strategy, and M&A for large U.S. pharmaceutical, biotech, and medical device companies. Worked for an upcoming academic medical center in Dubai.